Automated versus Manual Data Extraction of the Padua Prediction Score for Venous Thromboembolism Risk in Hospitalized Older Adults

被引:6
|
作者
Pavon, Juliessa M. [1 ,2 ,3 ]
Sloane, Richard J. [1 ,2 ,3 ]
Pieper, Carl F. [1 ,2 ,3 ]
Colon-Emeric, Cathleen S. [1 ,2 ,3 ]
Cohen, Harvey J. [1 ,2 ,3 ]
Gallagher, David [1 ]
Morey, Miriam C. [1 ,2 ,3 ]
McCarty, Midori [1 ]
Ortel, Thomas L. [1 ]
Hastings, Susan N. [1 ,2 ,3 ,4 ]
机构
[1] Duke Univ, Durham, NC USA
[2] Durham Vet Affairs Med Ctr, Geriatr Res Educ Clin Ctr, Durham, NC USA
[3] Duke Univ, Claude D Pepper Ctr, Durham, NC USA
[4] Durham Vet Affairs Hlth Care Syst, Hlth Serv Res & Dev Ctr Innovat, Durham, NC USA
来源
APPLIED CLINICAL INFORMATICS | 2018年 / 9卷 / 03期
关键词
decision support algorithm; venous thromboembolism; geriatrics; electronic health record and systems; inpatient; ADMINISTRATIVE DATA; AMERICAN-COLLEGE; PROPHYLAXIS; VTE; VALIDATION; ALGORITHM; ACCURACY; MEDICINE; VALIDITY; ICD-9-CM;
D O I
10.1055/s-0038-1670678
中图分类号
R-058 [];
学科分类号
摘要
Objective Venous thromboembolism (VTE) prophylaxis is an important consideration for hospitalized older adults, and the Padua Prediction Score (PPS) is a risk prediction tool used to prioritize patient selection. We developed an automated PPS (APPS) algorithm using electronic health record (EHR) data. This study examines the accuracy of APPS and its individual components versus manual data extraction. Methods This is a retrospective cohort study of hospitalized general internal medicine patients, aged 70 and over. Fourteen clinical variables were collected to determine their PPS; APPS used EHR data exports from health system databases, and a trained abstractor performed manual chart abstractions. We calculated sensitivity and specificity of the APPS, using manual PPS as the gold standard for classifying risk category (low vs. high). We also examined performance characteristics of the APPS for individual variables. Results PPS was calculated by both methods on 311 individuals. The mean PPS was 3.6 (standard deviation, 1.8) for manual abstraction and 2.8 (1.4) for APPS. In detecting patients at high risk for VTE, the sensitivity and specificity of the APPS algorithm were 46 and 94%, respectively. The sensitivity for APPS was poor (range: 6-34%) for detecting acute conditions (i.e., acute myocardial infarction), moderate (range: 52-74%) for chronic conditions (i.e., heart failure), and excellent (range: 94-98%) for conditions of obesity and restricted mobility. Specificity of the automated extraction method for each PPS variable was > 87%. Conclusion APPS as a stand-alone tool was suboptimal for classifying risk of VTE occurrence. The APPS accurately identified high risk patients (true positives), but lower scores were considered indeterminate.
引用
收藏
页码:743 / 751
页数:9
相关论文
共 50 条
  • [41] Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study
    Hu, Yuehong
    Li, Xiaoqian
    Zhou, Haixia
    Lin, Ping
    Zhang, Jiarui
    Huang, Dong
    Qi, Min
    Tang, Yongjiang
    Yi, Qun
    Liang, Zong'an
    Wang, Maoyun
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2020, 31 (04) : 454 - 460
  • [42] Khorana risk score and PROTECHT risk score as prediction models of venous thromboembolism in cancer outpatients receiving chemotherapy: a retrospective analysis
    Barni, S.
    Labianca, R.
    Verso, M.
    Gasparini, G.
    Bonizzoni, E.
    Mandala, M.
    Brighenti, M.
    Petrelli, F.
    Bianchini, C.
    Perrone, T.
    Agnelli, G.
    THROMBOSIS RESEARCH, 2012, 129 : S166 - S166
  • [43] Fall risk in older adults hospitalized with tumours: Contributing factors and prediction model
    Liu, Xiaoyan
    Dong, Chen
    Zhao, Rui
    Gu, Zhifeng
    Sun, Chi
    NURSING OPEN, 2023, 10 (10): : 7084 - 7091
  • [44] Construction and validation of a prediction model for fall risk in hospitalized older adults with osteoporosis
    Sun, Li
    Gu, Hai-Yan
    Xu, Guan-Hua
    Jiang, Jia-Wei
    Wang, Ting-Ting
    Li, Dan-Dan
    Cui, Bai-Hong
    FRONTIERS IN PUBLIC HEALTH, 2025, 12
  • [45] Impact of Clinical Decision Support with Mandatory versus Voluntary Venous Thromboembolism Risk Assessment in Hospitalized Patients
    Bahl, Vinita
    Moote, Marc J.
    Hu, Hsou Me
    Campbell Jr, Darrell A.
    TH OPEN, 2024, 08 (03) : e317 - e328
  • [46] Lymphoma-Specific Venous Thromboembolism Score (LyV-Score): Use of Lymphoma Subtype to Refine Risk Prediction
    Cao, Shufen
    Dharmavaram, Gouri
    Boughan, Kirsten M.
    Cooper, Brenda
    Gallogly, Molly M.
    Malek, Ehsan
    Metheny, Leland, III
    Otegbeye, Folashade
    Tomlinson, Benjamin K.
    de Lima, Marcos
    Fu, Pingfu
    Caimi, Paolo F.
    BLOOD, 2019, 134
  • [47] Framingham Risk Score and Alternatives for Prediction of Coronary Heart Disease in Older Adults
    Rodondi, Nicolas
    Locatelli, Isabella
    Aujesky, Drahomir
    Butler, Javed
    Vittinghoff, Eric
    Simonsick, Eleanor
    Satterfield, Suzanne
    Newman, Anne B.
    Wilson, Peter W. F.
    Pletcher, Mark J.
    Bauer, Douglas C.
    PLOS ONE, 2012, 7 (03):
  • [48] Validation of the Hospital Frailty Risk Score in older adults hospitalized with community-acquired pneumonia
    Rosario, Barbara H.
    Quah, Jessica Lishan
    Chang, Ting Yu
    Barrera, Vivian Cantiller
    Lim, Aileen
    Sim, Lydia Euphemia
    Conroy, Simon
    Dhaliwal, Trishpal Kaur
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2024, 24 : 135 - 141
  • [49] A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active Cancer
    Cohen, Alexander T.
    Wallenhorst, Christopher
    Choudhuri, Satarupa
    Nassar, Ayman
    Pollock, Kevin G.
    Martinez, Carlos
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (04) : 324 - 336
  • [50] Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
    Rupa-Matysek, Joanna
    Gil, Lidia
    Kazmierczak, Maciej
    Baranska, Marta
    Komarnicki, Mieczyslaw
    MEDICAL ONCOLOGY, 2018, 35 (01)